We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Generic Line
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Generic Line
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Groups Use Neupogen Biosimilar Vote to Highlight Outstanding Issues
Price:
$40.00
Learn More
Gilead Denied Sovaldi Patents in India, Paving Way for Generic Competition
Price:
$40.00
Learn More
Mylan, Abbott Submit Merger Proposals to Ease EU Antitrust Concerns
Price:
$40.00
Learn More
Actavis Keeping Namenda on Shelves, But Notification Mandate Waived
Price:
$40.00
Learn More
Actavis Gets Expedited Review in Namenda Appeal
Price:
$40.00
Learn More
Indian Court Blocks Cipla From Selling Novartis Generic
Price:
$40.00
Learn More
Judge Sides With FDA Over Colchicine 505(b)(2) Approval
Price:
$40.00
Learn More
FTC Tracks Slight Downturn in Pay-for-Delay Deals in FY 2013
Price:
$40.00
Learn More
2015 Guidance Expected on Social Media, Biosimilars and Quality Metrics
Price:
$40.00
Learn More
Uhl Named Permanent Director of Office of Generic Drugs
Price:
$40.00
Learn More
NICE Updates Process for Reviewing Biosimilars
Price:
$40.00
Learn More
Hospira Announces Epogen/Procrit Biosimilar Application, Fourth in U.S.
Price:
$40.00
Learn More
Previous
1
2
…
14
15
16
17
18
19
20
21
22
Next